Cannabis and the Gastrointestinal Tract.

CONCLUSIONS: With limited evidence of efficacy and safety of Cannabis in IBD, IBS, and NAFLD, randomized controlled studies are required to examine its therapeutic efficacy. Moreover, since long term use of the plant leads to drug use disorders the patients should be followed continuously. PMID: 32762830 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32762830?dopt=Abstract

Source: J Pharm Pharm Sci - August 13, 2020 Category: Drugs & Pharmacology Authors: Cohen L, Neuman MG Tags: J Pharm Pharm Sci Source Type: research